| Product Name | Icatibant Acetate - API |
| Product Code | DA-I113-a |
| Chemical name | Icatibant Acetate |
| Synonyms | ((2S,3aS,7aS)-1-((R)-2-(((S)-2-(2-((2S,4R)-1-(D-Arginyl-L-arginyl-L-prolyl)-4-hydroxypyrrolidine-2-carboxamido)acetamido)-3-(thiophen-2-yl)propanoyl)-L-seryl)-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)octahydro-1H-indole-2-carbonyl)-L-arginine compound with Acetic Acid (1:1); |
| Impurity | NA |
| CAS Number | 138614-30-9 |
| Alternate CAS # | NA |
| Molecular form | C61H93N19O15S |
| Appearance | White Solid |
| Melting Point | NA |
| Mol. Weight | 1364.59 |
| Storage | 2-8°C Refrigerator, Under inert atmosphere |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,Fine Chemicals,peptides |
| Boiling Point | NA |
| Applications | Icatibant Acetate is a bradykinin B2 receptor antagonist that has been recently approved for treatment of acute attacks of hereditary angioedema (HAE). |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
